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ABSTRACT 
This preliminary work consists in evaluating the superficial anticandidic activity of the leaves of Combretum racemosum P. Beauv in 
humans. To this end, we first demonstrated bioactive compounds of five (5) crude extracts (aqueous and hydro-organic 70%) from 
C. racemosum. Then, and finally, we have separately evaluated the superficial anticandidic activity of these extracts on Candida 
albicans, a species of genus Candida, mostly encountered in superficial human candidiasis. C. albicans was found to be sensitive to 
the five extracts tested. This partly justifies the use of C. racemosum in traditional medical practice against superficial microbial 
diseases. For these extracts, the Inhibitory Minimum Concentrations (MIC) recorded ranged from 7.8125 mg/mL to 62.550 mg/mL; 
While Fungicide Minimum Concentrations (CMF) range from 31.25 ± 0.00 mg/mL to 62.550 mg/mL. Concentrations for Fifty 
Percent Inhibition (IC50) range from 0.930 mg/mL to 3.861 mg/mL. The hydroethanolic macerated extract 70% (Eeth 70%) is the 
most active fraction on C. albicans (CMF = 7.8125 ± 0.00 mg/mL, IC50 = 0.941 ± 0.009 mg/mL) compared to the total of the five 
crude extracts tested. The preliminary phytochemical screening of the five crude extracts revealed the presence of alkaloids, 
saponins, terpenoids steroids and tannins (catechics and gallics) at various levels of concentration in our study. Eeth 70%, the most 
active extract in our work, contains in medium concentrations the same active ingredients cited above.  Finally, we note that the 
hydroethanolic macerated extract 70% is the most active fractions in this work. It may, however, subject to toxicological studies, be 
used in the treatment of theskin, the cutaneous appendages and the mucous membranes in humans. 
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1. INTRODUCTION 
The skin, the cutaneous appendages and the mucous 
membranes constitute the first natural defenses of the 
living organism against external aggressions of any kind, 
in particular the microbial invasions
1
. They contain, in 
fact, physical, chemical and biological parameters, in 
particular microbial parameters, essential for the survival 
of the living body. Consequently, they require regular 
and rigorous hygiene, and in case of external microbial 
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aggressions, adequate and immediate medicinal 
treatments. 
The genus Candida is a group of commensal yeast 
species of humans and other animals, opportunistic 
pathogens, keratinophilic and having an affinity for 
keratinized tissue to cause superficial and invasive 
candidiasis. 
At the global level, for example in Central Africa, 
species of the genus Candida are at the forefront of 
opportunistic leprosy in healthy people and those living 
with HIV, and are the cause of pathological 
manifestations of AIDS 
2
. Moreover, in recent years, the 
incidence of previously unrepresented candidiasis 
species is responsible for the increased frequency of 
yeast infections 
3
. As an indication, Candida   albicans is 
today, the most pathogenic and wide spread Candida 
4
. 
However, although it is the most widespread species, 
these other species defined as non-albicans have, in 
recent years, a higher prevalence related to ecology 
5
. 
Moreover, in Côte d'Ivoire in particular, a 2008 study in 
Abidjan on C. albicans, the most pathogenic and most 
frequently isolated Candida, showed that C. albicans 
accounted for 72.6% of the original strains vaginal 
disorders 
6
. 
The superficial candidiasis, the object of this study, is 
opportunistic infections due to yeasts of the genus 
Candida, which affect the epidermis of the skin, the 
cutaneous appendages and the mucous membranes 
7
. 
They represent the most frequent and natural candidiasis 
in the intestine, folds and buttocks, especially in young 
children 
8
. They are cosmopolitan, recurrent and 
recurring superficial fungal infections that are difficult to 
cure in some cases, do not threaten   life,   but cause   
physical   discomfort   for   those   affected   and   may   
be   factors   that contribute   to   serious   diseases   
including   HIV infections 
9
.  They   often   lead   to   
deaths   in immune compromised individuals because of 
recurrence and difficulties in curing somecases.  Overall, 
the rate of the global population with superficial 
candidiasis ranges from 70% to 80%; babies,   children   
and immune compromised persons   are the first victims 
10, 11
. This frequency has increased steadily in recent 
years, with five to six recurrences a year. Moreover, the 
risk of complications of these infections in immune 
compromised subjects, for example indigestive 
candidiasis patients, is enormous and the mortality rate 
varies from 40 to 60% 
12
. 
On the other hand, conventional   modern   medicines 
such as azoles, allylamines, equinocandins and polyenes 
are effective against fungal infections and are currently 
available on the market 
13
. However, they are limited in 
number; costly, difficult to access by the poor and do not 
always correspond to the effective treatments for these 
diseases 
14
. However, they consist of heavy drug 
treatments, not without undesirable side effects and 
constitute on the market, the main therapies used 
15; 16
. 
Another major problem with these modern medicines is 
he resistance that certain pathogenic organisms put in 
place against these drugs, which, moreover, have quite 
high toxicity a few times 
17; 18
. 
All these factors listed above make it necessary to 
develop new, effective, low-toxicity medicines that are 
readily available to populations from all walks of life. 
This research would be based on plants, because they are 
an important source of an immense variety of bioactive 
molecules
19
. Moreover, these phytomolecules have 
multiple interests used in industry, food, cosmetology 
and dermopharmacy. Among these molecules are 
alkaloids, coumarins, quinones, phenolic compounds, 
tannins, lignins, flavonoids and terpenes 
20; 21
. 
On the international markets, demand for natural herbal 
medicines is also high. Today, according to the WHO, 
this demand is estimated at about 81% and represents for 
humanity, primary health care
22
. Combretum racemosum 
P.   Beauv. could meet this demand. Combretum 
racemosum P. Beauv. is a very common shrub of the 
genus Combretum and widely used in African traditional 
medicine for its antimicrobial activities
23; 24
.  Several 
scientific studies have been carried out on species of the 
family Combretaceae of which it forms part 
25
. 
However, so far no special report has been made on C. 
racemosum against superficial candidiasis. 
This work consisted in evaluating the superficial 
anticandidic activity of five crude extracts (aqueous and 
hydro-organic 70%) of C. racemosum in humans. In 
addition, a preliminary triphyochemical study of the 
various extracts was also carried out. 
2. MATERIALS AND METHODS 
2-1. Plant material 
The plant material used consists of fresh leaves of C. 
racemosum. This plant is found in East Africa, in the 
forestry recruits of the Guineo-Congolese region, in 
Senegal and Cameroon. It is also found in southern 
Nigeria where, in view of its therapeutic utility, it bears 
the name "Ebi-odo" or "Rose de Noel" 
26; 27
. In Côte 
d'Ivoire, C. racemosum occurs in the southern forest 
zone; It is known under the vernacular name of betso (in 
the Attié language in the Department of Anyama) and 
calo wôrô (in the Bambara language). It is a large 
climbing vine or a sprouting shrub up to 25-30 m long.  
The leaves, ovate or elliptic, acuminate and rounded at 
the base, average 10 cm in length and 5 cm in width. 
They include about 8 to 10 lateral ribs. The 
inflorescences, of the pancicles of short speciform races, 
are remarkable for the white bractal leaves, the terminal 
or axillary clusters of yellow flowers. The flowers have 
5 free sepals and 5 petals. They have 6 to 7 fertile 
stamens, very long anthracenes and poricides. The fruits, 
with four wings, are white- greenish or pinkish in the 
fresh state. 
These leaves of  C. racemosum  are collected in June 
2015 in the Department of Anyama (Côte d'Ivoire) and 
authenticated by Professor AKE Assi at the National 
Floristic Center of the University Félix Houphouët 
Boigny of Abidjan where samples are deposited 
Herbarium of the Plant under No. 19649, on 17 July 
1985. These sheets were used to make powders and then 
the five crude extracts (aqueous and hydro-organic 
70%).   
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2-2. Candidic isolates used 
The candidosic isolate used is Candida albicans (13-
304). Candida albicans is a commensal filamentous 
yeast of the skin and mucous membranes which, under 
special conditions, cause acute, subacute   or chronic 
candidiasis of   the skin, mucous   membranes and more 
rarely visceral and generalized 
28
. Among the yeasts of 
the genus Candida, it is the most widespread but also the 
most pathogenic species of superficial candidiasis. It 
infects newborns, immune suppressed individuals, 
diabetics and surgical patients, as well as healthy people. 
For example, 75% of women have had vaginal 
candidiasis in C. albicans and 5% have chronic 
candidiasis 
29.
 
The choice of C. albicans is made because of its majority 
(60%) involvement in superficial and invasive 
candidiasis. 
Our strain of C. albicans (13-304) is supplied by the 
Laboratory of Mycology of the Institute Pasteur of Ivory 
Coast (IPCI). It is derived from the vaginal sampling of 
AIDS patients from infectious diseases. 
2-3. Plant treatments and sampling 
After identification, the leaves of C. racemosum are first 
thoroughly sorted and freed from foreign bodies. They 
are then washed with distilled water, cut and dried out of 
the sun and in the open air. After drying, they are 
sprayed using a Culatti type Mfc electric grinder. 
Finally, the fine powder obtained is stored in sterile, 
clean and dry bottles. The whole is kept away from 
moisture and at ambient temperature of the laboratory to 
serve the preparation of the five crude extracts (aqueous 
and hydro-organic 70%). 
2-4. Preparation of aqueous crude extracts 
The macerated aqueous crude extract (codified Eaq) is 
obtained according to the following method 
30
: 
100 g of leaf powder are homogenized in 1 liter (1 L) of 
distilled water in a mixer at room temperature. The 
homogenate obtained is first drained through a square of 
white cloth. Then, double filtered on hydrophilic cotton 
(ref: 87071) and once on 3 mm wattman paper. The 
filtrate obtained is concentrated in an oven at 50 ° C. to 
give the macerated aqueous crude extract (Eaq). 
The soaked aqueous crude extract (codified Edec) is 
obtained according to the following method 
31
:  
100 g of leaf powder is first dissolved in one liter (1 L) 
of cold distilled water in a beaker. The whole is then 
boiled for 15 minutes on a hot plate, and homogenized in 
a blender (Mixer) at room temperature. At the end of the 
homogenization, the homogenate obtained is first 
drained through a square of white cloth. Then, double 
filtered on hydrophilic cotton (ref.: 87071) and once on 
3 mm wattman paper. The filtrate obtained is 
concentrated in an oven at 50° C. 
The Eaq and the Edec obtained are finally stored in 
sterile, clean and dry bottles and then kept away from 
heat and humidity to be separately used for the 
evaluation of the bioactive compounds and the surface 
anticandidosic activity. 
2-5. Preparation of the hydro-organic crude extracts 
70% 
The macerated hydroacetate extract 70% (codified Eace 
70%) is prepared according to the following method 
32
: 
100 g of leaf powder is dissolved in one liter (1 L) of a 
solution of cold water and pure ethyl acetate (300 mL of 
cold distilled water per 700 mL of pure ethyl acetate 
99.5° G.L) and then homogenized in a blender. After 
homogenization in a blender at room temperature, each 
homogenate obtained is first filtered through a square of 
white cloth. Then, double filtered on hydrophilic cotton 
(ref: 87071) and once on 3 mm wattman paper. The 
filtrate obtained is concentrated in an oven at 50 ° C. 
The macerated hydro-ethanolic crude extract 70% 
(codified Eeth 70%) and macerated hydro-methanolic 
crude extract 70% (codified Emet 70%) are prepared 
according to the preceding method 
32.
 However, the 
purity of ethanol is 96° G.L while that of methanol is 
99.85° G.L. 
The masses of Eace 70%, Eeth 70% and Emet 70% 
obtained are stored in sterile, clean, dry bottles then 
stored away from heat and humidity to be separately 
used For the evaluation of the bioactive compounds and 
then the superficial anticandidosic activity. 
 2-6. Phytochemical screening of the various C. 
racemosum extracts 
The five crude extracts of C. racemosum are distinctly 
subjected to a phytochemical screening for secondary 
metabolites contained in the leaves of the plant 
33
. Each 
bioactive compound is demonstrated in accordance with 
the method of Mangambu et al. 
34
. It is a set of 
identification reactions and colored indicators based on 
the reduction (alkaline or basic) of the reagent mixture 
by the oxidizable groups of the bioactive compounds, 
leading to the formation of color   reduction products   
which are a function of the environment. For each   
extract, 10 screening tests per colored reactions are 
carried out. Solutions with indicators have a positive 
reaction; This indicates the presence of bioactive 
compounds in the extracts and therefore in the leaves of 
C. racemosum. 
2-7. Evaluation of the superficial anticandidosic 
activity of the various extracts 
2-7.1. Preparation of culture media 
Sabouraud agar (ref: Bio-RAD, batch: C8B2212, n° 
74994) buffered to pH 5.7 is used for this test. The 
medium of culture is prepared according to the 
instructions of the manufacturer's protocol. 
The incorporation of extracts of C. racemosum in 
Sabouraud agar is carried out using the method of 
double dilution of agar on slopes 
35; 36
. For each C. 
racemosum extract, each series consists of 10 test tubes. 
Eight (8) of these test tubes contain extract. And the 
other two tubes are considered as control tubes. Of these 
two (2) tubes, one extract was used as control for growth 
control of C. albicans while the other without C. albicans 
strain and without extract was used as a control for the 
sterility control of Sabouraud agar. The eight (8) test 
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tubes with concentrations ranging from 125 to 0.78 mg / 
mL are bound by a geometric reason of ½. All the tubes 
are autoclaved at 121° C. for 15 minutes and then 
inclined at ambient temperature to allow the cooling and 
solidification of Sabouraud agar 
37
. Ketoconazole is used 
as a drug control. 
2-7.2. Anticandidosic test 
The candidosic inoculum is prepared from culture of 48 
hours of young colonies of C. albicans, previously 
isolated   from Yeast glucose chloramphenicol (ref.: 
51078, batch: 777666501) which is a microscopic fungal 
selective   medium   supplied by Biomedis. One (1) 
colony of C. albicans is removed and homogenized in 10 
mL of sterilized distilled water to obtain a 100 germ 
suspension. On dilution to 1/10, 1 mL of this suspension 
is transferred and homogenized in 9 mL of sterilized 
distilled water to give a final volume of 10 mL to 
suspension 10
-1
. The latter is stored for inoculation at the 
rate of 10 μL per tube. 
The anticandidosic   test concerns the 8 test tubes and 
the growth control (Tc) control. Thousand (1000) cells 
of C. albicans, equivalent to 10 μL, are seeded by 
transverse streaks tight until exhaustion; on Sabouraud 
agar medium prepared before hand 
38
. 
For each extract, all tests are carried out by triplicates. 
The cultures are incubated at 30 ° C. for 48 hours. They 
are used to determine the superficial anticandidosic 
activity. 
2-8. Determination of the anticandidosic activity of 
the various extracts 
This part concerns microbiological factors: colony 
counts of C. albicans, determination of antifungal   
parameters   (MIC, CMF and IC50) and the growth curve 
of C. albicans. 
2-8.1. Enumeration of Candidate Colonies 
After this incubation time, the colonies of C. albicans are 
first counted by direct counting with a colony counting 
pen (serial number of Cebeware 23382, brand Bel-Art), 
then, and finally, growth in 10 experimental tubes on the 
percent survival is evaluated, compared to 100% 
survival in the Tc growth control pilot tube 
39.
 
2-8.2. Determination of antifungal parameters 
After counting the colonies, the value of each antifungal 
parameter is determined. Data processing allows for 
minimum values of inhibitory concentrations (MIC), 
fungicide concentration (CMF), graphically to determine 
on the activity curves of the extract 50% of the 
inhibition concentration values (IC50) and activity report 
(CMF/CMI). 
The MIC is here the concentration of extract of C. 
racemosum in the tube for which there was no visible 
growth with the naked eye. CMF is the concentration of 
extract which gives 99.99% inhibition as compared to 
the growth control tube. The IC50 is determined 
graphically from the sensitivity curve of C. albicans to 
each extract. 
2.9. Statistical analysis 
The values of the antifungal parameters of each extract 
are determined using the Graphpad software. The results 
are given as mean ± SE (n = 4), using Colum Statistica. 
3. RESULTS AND DISCUSSION 
In this work, bioactive compounds (active ingredients) 
of the five crude extracts (aqueous and   hydro-organic 
70%)   of C. racemosum leaves are demonstrated by 
phytochemical screening. The in-vitro anticandidosic 
activity of these extracts is also evaluated with respect to 
C. albicans. 
3-1. Bioactive compounds 
The results of the phytochemical screening of the five 
crude extracts of C. racemosum leaves are shown in 
table 1. Analysis of these results clearly reveals the 
presence in the five extracts of alkaloids, flavonoids, 
phenolic compounds, saponins, steroids,  terpenoids and 
tannins (catechics and gallics) in varying degrees of 
concentration (table 1). 
The 70% (70% Eeth) hydroethanolic crude extract 
contains alkaloids, saponins, steroids, terpenoids and 
tannins (catechic and gallic) at medium concentrations 
(table 1). 
 
Table 1: Bioactive compounds of the five leaf extracts of C. racemosum 
Eaq:  Macerated aqueous crude extract;    
Edec: Soaked aqueous crude extract; 
Eace 70 %: Crude  Macerated  hydro-
ethyl acetate crude extract 70%;     
Eeth70 %:  Macerated  hydro-ethanolic 
crude extract 70%;     Emet 70 %: 
Macerated hydro- methanolic  crude   
extract  70%;        B:  Bouchardat;  D:   
Dragendorff;  Cat:   Catechics;  Gal:   
Gallics;   -:  Lack   of  bioactive 
compounds; +: Weak of bioactive 
compounds; ++: Medium concentration 
of bioactive compounds;  +++: High 
concentration of bioactive compounds 
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By triphyochemical studies confirmed on C. racemosum 
extracts, similar results have been obtained by Harbone, 
Onocha et al. (a), Okwuosa  et al. and Kamou et al.
40; 41; 
42; 43
. These results could confirm in part the use in 
traditional C. racemosum against microbial superficial 
infections. These compounds are already known for 
their antimicrobial activities 
44, 45, 46
. 
Mcgaw et al., Have also demonstrated the presence of 
these secondary metabolites in a hydro-ethanolic crude 
extract (Eeth 70%) 
47.
 
3-2. Superficial anticandidosic activity of the 
different extracts 
The anticandidic activity of each C. racemosum crude 
extract was evaluated. The values of the antifungal 
parameters are determined (figure 1, table 2). Analysis 
of the experimental results shows that, compared with 
growth control (TC) controls, there is a decrease in the 
number of C. albicans colonies in the test tubes as the 
concentration of each extract increases (figure 1). The 
curve that characterizes this decrease shows a 
decreasing rate (figure 1). Thus, our results show that 
the five (5) extracts tested are active at various levels 
ranging from 7.8125 ± 0.00 mg / mL to 62.5 ± 0.00 mg / 
mL and show anticandidic activity by inhibiting. The in-
vitro growth of C. albicans in a dose-response 
relationship.  
The sensitivity of C. albicans to each extract as well as 
the curve obtained make it possible to determine the 
different antifungal parameters of each extract, namely 
the Minimum Inhibitory Concentration (MIC), the 
Minimum Fungicidal Concentration (CMF), the 
Concentration for Fifty percent Inhibition (IC50) as well 
as the activity report (CMF/CMI) (table 2). 
 
 
Figure 1: Sensitivity of C. albicans to C. racemosum extracts 
Table 2: Superficial anticandidosic activity of C. racemosum five crude extracts tested 
 
Eaq: Macerated aqueous crude extract;     Edec: Soaked aqueous crude extract; Eace 70 %:  Macerated hydro-ethyl acetate 
crude extract 70%;    Eeth 70 %: Macerated hydro-ethanolic crude extract 70%; Emet 70 %: Macerated hydro-methanolic 
crude extract 70%;Ket: ketoconazole, MIC: Minimum Inhibitory Concentration; CMF: Minimum Concentration Fungicide; 
IC50: Concentration for Fifty percent Inhibition 
The sensitivity of the C. albicans strain to the five 
extracts tested justifies in part the use in traditional C. 
racemosum P. Beauv. against microbial diseases. In 
separate studies evaluating phytochemical and 
antimicrobial properties of leaf extracts of C. 
racemosum  validated, Onocha  et al. (b) and Okwuosa  
et al., also showed the sensitivity of C. albicans  to crude 
aqueous, ethyl acetate, methanolic and hexanic extracts 
of C. racemosum 
48; 49
. The synergistic action of   
alkaloids, flavonoids, phenolic compounds, saponins, 
steroids, terpenoids and tannins at various degrees of 
concentration would be the basis of the anticandidosic 
activity observed in the five crude extracts in our study. 
Indeed, alkaloids, for example, are endowed with 
antimicrobial properties 
50
. Flavonoids, tannins and 
triterpenoids are   recognized as antifungal molecules 
51
. 
Kamou et al                                                                                                            Journal of Drug Delivery & Therapeutics. 2017; 7(5):53-60                           
ISSN: 2250-1177                                                                              [58]                                                                            CODEN (USA): JDDTAO 
Flavonoids are in particular responsible for the 
antiallergic, antiparasitic   power and also inhibit the 
activation of the supplements 
52; 53
. Phenolic compounds 
have been found to have antibacterial and antifungal 
activities, and are indeed natural compounds widely 
distributed in the plant kingdom, which are of increasing 
importance, in particular because of their beneficial 
effects on health 
54
. They are also used as additives in 
the food, pharmaceutical and cosmetic industries 
55.
 
The five extracts tested were fungicide on the strain of 
C. albicans studied. For the five extracts, the recorded 
MIC ranged between 7.8125 ± 0.00 mg/mL and 62.5 
mg/mL for C. albicans;   while   CMF   ranges from 
7.8125 ± 0.00   mg/mL to 62.5 mg/mL. IC50 range from 
0.930 ± 0.010 mg/mL to 3.861 ± 0.009 mg/mL.  
The macerated hydro-ethanolic extract 70% (Eeth 70%) 
is the most active fraction compared to the others on C. 
albicans (CMF = 31.25 ± 0.00 mg/mL, IC50 = 1.910 ± 
0.009 mg/mL). This activity is comparable to that of the 
reference drug ketoconazole tablet (CMF = 7.65x10-3 
±0.00 mg/mL, IC50 = 4.653x10-6 ± 1.528x10-8 mg/mL. 
The nature of the Eeth 70% bioactive compounds could 
justify the high anti-candidosic activity compared to the 
other extracts. The activity of Eeth 70% is indeed due to 
alkaloids, saponins, steroids, terpenoids and tannins. 
These ethano-soluble molecules, which were moderately 
concentrated in this extract, were then able to express   
their   anticandidosic potential better, hence the activity 
obtained. 
Alkaloids, for example, generally have an important 
function in biological structures; they are also potent 
anticholinergics and are known for their high 
antibacterial potency 
56;   57
. The activity of Eeth 70% is 
attributed in part to the alkaloids which not only are 
concentrated in Eeth 70% but also possess strong 
antifungal activity according to the literature. An 
analysis of the CMI values shows that Eeth 70% 
enhances anticandidosic activity than the other extracts. 
We recall that the activity of a plant substance depends 
on several factors including the mode of extraction and 
the concentration of active ingredient 
58;   59
. 
The activity report (CMF/CMI) of Eeth 70% for C. 
albicans is one (1). The Eeth 70% thus has a fungicidal 
activity against C. albicans. This extract can therefore be 
described as a fungicidal substance. When the activity 
ratio (CMF/MIC) of an antimicrobial substance is less 
than or equal to four (≤ 4), the latter is referred to as a 
fungicidal substance and if the CMF/MIC ratio is greater 
than four (> 4), then it is called fungistatic 
60.
 
4. CONCLUSION AND PERSPECTIVES 
This analytical study, which consisted in demonstrating 
bioactive compounds and evaluating the superficial 
anticandidosilic activity of five crude extracts of 
Combretum   racemosum, makes it possible to conclude 
that all the extracts analyzed contain bioactive 
compounds at various degrees of concentration. The 
macerated hydro-ethanolic crude extract 70% (Eeth70%) 
contains, in medium concentrations, the same 
compounds mentioned above. 
The C. albicans strain studied is sensitive to the five 
extracts tested. This sensitivity is different depending on 
the extract. C. albicans is more sensitive to Eeth 70%, 
while it is more resistant to macerated hydro-ethyl 
acetate crude extract 70% (Eace 70%). Eeth 70% of C. 
racemosum is the most active fraction on C. albicans. It 
concentrates the active ingredients better. 
Taking into account the results obtained in this work, 
Eeth 70% could, after toxicological studies, be used as 
phytomedicine to combat skin, mucosal and skin 
apposition in humans.  
In our future work, we will first prepare the partitioned 
extract of the Eeth 70% of C. racemosum, then purify its 
phytomolecules which we will test again on C. albicans. 
Finally, we will be interested in the toxicological study 
of Eeth 70% on laboratory animals. 
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